An increased sense of urgency is needed as the world falls behind
Since introduction in 2006, HPV vaccines have proven safe and effective in protecting against infection and preventing cervical cancer. Yet, the burden of HPV diseases continues to rise with an estimated 600,000 new cases of cervical cancer and over 340,000 deaths each year.
To respond to these life-threatening trends, the Sabin Vaccine Institute, as consortium secretariat, along with a diverse, and expanding, set of partners will mobilize action across three pillars:

The Global HPV Consortium will be guided by global goals, including WHO’s Immunization Agenda 2030 and Cervical Cancer Elimination Initiative:
